Satchi-Fainaro Ronit

SEC Form 4 insider trading activity

Satchi-Fainaro Ronit has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 25, 2026.

On the most recent filing, Satchi-Fainaro Ronit is listed as Director at TEVA PHARMACEUTICAL INDUSTRIES LTD. Inside the rolling window, Satchi-Fainaro Ronit reported no open-market purchases and 1 open-market sale totaling $15K in TEVA.

Companies traded

Other insiders at TEVA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$15K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TEVA
Satchi-Fainaro Ronit
Sale$15KAug 25SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Satchi-Fainaro Ronit made?

Satchi-Fainaro Ronit has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.

Which companies does Satchi-Fainaro Ronit trade?

Satchi-Fainaro Ronit has filed SEC Form 4 disclosures for 1 company, including TEVA.

When was Satchi-Fainaro Ronit's most recent SEC Form 4 filing?

Satchi-Fainaro Ronit's most recent SEC Form 4 filing on Tracefour is dated Aug 25, 2026.

What is Satchi-Fainaro Ronit's total buy and sell value in the current window?

Inside the rolling retention window, Satchi-Fainaro Ronit bought $0 and sold $15K based on SEC Form 4 filings.

What was Satchi-Fainaro Ronit's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 415 TEVA shares on 2026-08-21, worth $15K, per SEC Form 4 filings.